Latest & Greatest

Latest & Greatest

Recent developments in the field of hematology/oncology, including drug approvals, policy updates, and clinical trial results

FDA Expands Approval of Ferumoxytol Injection for Iron Deficiency Anemia

The FDA approved a supplemental new drug application for ferumoxytol injection to include all eligible adults with iron-deficiency anemia (IDA) who cannot tolerate or...

Firstline Eltrombopag Receives Breakthrough Designation for Severe Aplastic Anemia

The FDA granted breakthrough-therapy designation for firstline eltrombopag to treat severe aplastic anemia (SAA). The thrombopoietin receptor agonist received this designation based on research conducted...

Tax on Medical Devices Resumes After Two Years

In January, the 2.3 percent excise tax for medical devices was resumed, after a two-year hiatus. The tax was originally imposed in 2013 as...

IV Bag Shortage Making Flu Season Worse

Supplies of intravenous (IV) saline and nutrient solutions were already tight before hurricanes hit Puerto Rico in September of last year and cut power...

Study Claims Medicaid Changes Could Lead to Hospital Closures

Researchers are cautioning that undoing Medicaid expansions (which occurred under the ACA) may lead to hospital closures. Decreased Medicaid revenue would be to blame,...

Study Confirms Risk of Breast Implant-Associated ALCL

After investigating 359 reports linking silicone and saline breast implants with the development of anaplastic large cell lymphoma (ALCL), the FDA found that women...

Denosumab Receives FDA Approval for the Prevention of Skeletal-Related Events in Those With MM

The FDA approved the sBLA for the RANK ligand inhibitor denosumab, expanding its indication to include the prevention of skeletal-related events (SREs) in patients...

FDA Grants Priority Review to Brentuximab Vedotin in Combination With AVD for Frontline Treatment...

The U.S. Food and Drug Administration (FDA) granted priority review to a supplemental biologics license application (sBLA) for brentuximab vedotin in combination with AVD...

Three Corporate Giants Team Up to Disrupt Health Care

Amazon, Berkshire Hathaway, and JPMorgan Chase announced that they will form an independent health-care company for their employees in the U.S. The companies said the...

CDC Director Resigns Over Conflicts of Interest

Brenda Fitzgerald, MD, director of the Centers for Disease Control and Prevention (CDC), resigned from her appointment over financial conflicts of interest involving investments...
Advertisement

Current Issue

June 2018, Volume 4, Issue 7

This issue features a look at gaining oral parity for cancer medications, the unavoidable "bubbles" in which people live and work, and more.